[HTML][HTML] Estrogen receptor signaling in breast cancer

P Miziak, M Baran, E Błaszczak… - Cancers, 2023 - mdpi.com
Simple Summary Estrogens, belonging to a group of steroid compounds, play an important
role in both physiological and disease processes, mainly by interacting with estrogen …

Lysine acetylation goes global: from epigenetics to metabolism and therapeutics

I Ali, RJ Conrad, E Verdin, M Ott - Chemical reviews, 2018 - ACS Publications
Post-translational acetylation of lysine residues has emerged as a key regulatory
mechanism in all eukaryotic organisms. Originally discovered in 1963 as a unique …

Membrane and nuclear estrogen receptor alpha actions: from tissue specificity to medical implications

JF Arnal, F Lenfant, R Metivier, G Flouriot… - Physiological …, 2017 - journals.physiology.org
Estrogen receptor alpha (ERα) has been recognized now for several decades as playing a
key role in reproduction and exerting functions in numerous nonreproductive tissues. In this …

Estrogen receptors: new directions in the new millennium

SC Hewitt, KS Korach - Endocrine reviews, 2018 - academic.oup.com
Nineteen years have passed since our previous review in this journal in 1999 regarding
estrogen receptors. At that time, we described the current assessments of the physiological …

HDAC inhibitors as epigenetic regulators of the immune system: impacts on cancer therapy and inflammatory diseases

EE Hull, MKR Montgomery… - BioMed research …, 2016 - Wiley Online Library
Histone deacetylase (HDAC) inhibitors are powerful epigenetic regulators that have
enormous therapeutic potential and have pleiotropic effects at the cellular and systemic …

Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs

HJ Kim, SC Bae - American journal of translational research, 2010 - pmc.ncbi.nlm.nih.gov
Histone deacetylase (HDAC) inhibitors are a relatively new class of anti-cancer agents that
play important roles in epigenetic or non-epigenetic regulation, inducing death, apoptosis …

Acetylation and deacetylation of non-histone proteins

MA Glozak, N Sengupta, X Zhang, E Seto - gene, 2005 - Elsevier
Since the first report of p53 as a non-histone target of a histone acetyltransferase (HAT),
there has been a rapid proliferation in the description of new non-histone targets of HATs. Of …

Histone deacetylase inhibitors: overview and perspectives

M Dokmanovic, C Clarke, PA Marks - Molecular cancer research, 2007 - aacrjournals.org
Histone deacetylase inhibitors (HDACi) comprise structurally diverse compounds that are a
group of targeted anticancer agents. The first of these new HDACi, vorinostat …

Principles for modulation of the nuclear receptor superfamily

H Gronemeyer, JÅ Gustafsson, V Laudet - Nature reviews Drug …, 2004 - nature.com
Nuclear receptors are major targets for drug discovery and have key roles in development
and homeostasis, as well as in many diseases such as obesity, diabetes and cancer. This …

Changes in proinflammatory cytokine activity after menopause

J Pfeilschifter, R Köditz, M Pfohl, H Schatz - Endocrine reviews, 2002 - academic.oup.com
There is now a large body of evidence suggesting that the decline in ovarian function with
menopause is associated with spontaneous increases in proinflammatory cytokines. The …